ProHealth fibromyalgia Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|

Trending News

Piriformis Syndrome in Fibromyalgia

Sensory Distress: The Other Side of Fibromyalgia

Patient Harm: The Facts and the Effects of Fibromyalgia Diagnostic Criteria

Small Fiber Neuropathy Fibromyalgia Studies Mount: But Does SFN Cause Pain in FM?

The Functional Capacity Evaluation (FCE) and Your Disability Insurance Benefits

Study Finds Serotonin Decreases Sensitivity to Pain

SURVEY RESULTS: Cognitive Impairment

Novel Fibromyalgia Treatment Shows Promise in Study

Connectivity Between Brain Regions May Predict Fibromyalgia Drug Treatment Response

Fibromyalgia-Friendly Turkey Day Recipe Tips and Swaps

 
Print Page
Email Article

U of Utah Recruiting Fibromyalgia & FM/CFS Patients for Pregabalin Biomarker Study

  [ 3 votes ]   [ Discuss This Article ]
www.ProHealth.com • July 12, 2012


Why does Lyrica® (generic name pregabalin) help some FM patients and not others?

The Department of Anesthesiology at the University of Utah, Salt Lake City, announced July 10 that it is seeking participants for a study to investigate Lyrica’s “effects on blood biomarkers” in patients with fibromyalgia or FM & chronic fatigue syndrome (ME/CFS).

Lyrica (pregabalin) is a prescription drug marketed by Pfizer that gained FDA approval in 2007* for treatment of fibromyalgia.

Study Details

According to the July 10 blood biomarkers study announcement:

• Researchers hope to learn more about why Lyrica is effective for some patients and not for others.

• Volunteers with fibromyalgia (FMS) or chronic fatigue syndrome and FMS who are not currently using Lyrica are needed to participate in this IRB-approved trial.

• Eligible volunteers will receive Lyrica for five weeks and a placebo for five weeks, and will be compensated for their time.

• For more information, contact Andrea White (andrea.white@hsc.utah.edu)
___
* As Pfizer's Lyrica patents begin expiring, in October 2013, the $3.4 billion annual Lyrica market will be opening to ‘generic’ (generally lower price) versions of the drug, and as of July 5, the FDA approved marketing of a generic pregabalin product by Lupin Pharmaceuticals.



Please Discuss This Article:   Post a Comment 



[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Black Friday Sale

Featured Products

Fibro Freedom™ Fibro Freedom™
Soothes, strengthens & revitalizes
FibroSleep™ by ProHealth FibroSleep™ by ProHealth
The All-in-One Natural Sleep Aid
B-12 Extreme™ B-12 Extreme™
The Most Potent Vitamin B-12 on Earth
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Optimized Curcumin Longvida® by ProHealth Optimized Curcumin Longvida® by ProHealth
Supports Cognition, Memory & Overall Health

Natural Remedies

Anti-Inflammatory Properties of Tart Cherry Anti-Inflammatory Properties of Tart Cherry
Why Berries Offer a Rainbow of Health Benefits Why Berries Offer a Rainbow of Health Benefits
Dreaming of a Good Night's Sleep? Dreaming of a Good Night's Sleep?
Live Longer: Groundbreaking Research on Omega-3s Live Longer: Groundbreaking Research on Omega-3s
Three-Step Strategy to Reverse Mitochondrial Aging Three-Step Strategy to Reverse Mitochondrial Aging

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing